Prevention of HIV-1 transmission with postexposure prophylaxis after inadvertent infected blood transfusion
- PMID: 24896805
- PMCID: PMC4226216
- DOI: 10.1097/QAD.0000000000000268
Prevention of HIV-1 transmission with postexposure prophylaxis after inadvertent infected blood transfusion
Conflict of interest statement
Similar articles
-
Antiretroviral Medications for the Prevention of HIV Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention.Infect Dis Clin North Am. 2019 Sep;33(3):629-646. doi: 10.1016/j.idc.2019.04.002. Epub 2019 Jun 22. Infect Dis Clin North Am. 2019. PMID: 31239092 Review.
-
Is postexposure prophylaxis with antiretroviral therapy necessary in cases of blood exposure through a fight when HIV-1 status is unknown?AIDS. 2014 Jan 2;28(1):137-9. doi: 10.1097/QAD.0000000000000028. AIDS. 2014. PMID: 24413265 No abstract available.
-
Current world literature.Curr Opin HIV AIDS. 2010 Jul;5(4):350-5. doi: 10.1097/COH.0b013e32833b7942. Curr Opin HIV AIDS. 2010. PMID: 20539087 No abstract available.
-
Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy.Infect Dis (Lond). 2016 Feb;48(2):93-8. doi: 10.3109/23744235.2015.1089593. Epub 2015 Sep 28. Infect Dis (Lond). 2016. PMID: 26414596 Review.
-
Safety of 6-week Neonatal Triple-combination Antiretroviral Postexposure Prophylaxis in High-risk HIV-exposed Infants.Pediatr Infect Dis J. 2019 Oct;38(10):1045-1050. doi: 10.1097/INF.0000000000002426. Pediatr Infect Dis J. 2019. PMID: 31365477
Cited by
-
Human Immunodeficiency Virus (HIV).Transfus Med Hemother. 2016 May;43(3):203-22. doi: 10.1159/000445852. Epub 2016 May 9. Transfus Med Hemother. 2016. PMID: 27403093 Free PMC article. No abstract available.
References
-
- Panlilio AL, Cardo DM, Grohskopf LA, Heneine W, Ross CS. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep. 2005;54:1–17. - PubMed
-
- Smith DK, Grohskopf LA, Black RJ, Auerbach JD, Veronese F, Struble KA, et al. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR Recomm Rep. 2005;54:1–20. - PubMed
-
- Oliveira CFd, Diaz RS, Harmache A, Frenkel LM, Gupta P, Learn GH, et al. Passive Transfer of HIV-1 Antibodies and Drug Resistant Virus during a Health Care Worker Accident: Implications for HCW Post-Exposure Management. Am J Infect Dis. 2008;4:244–256.
-
- Salomao R, Oliveira JS, Oliveira CF, Diaz RS, Minelli H, Valdetaro F. Passive transfer of HIV-1 antibodies and absence of HIV infection after the transfusion of HIV-1-seropositive red cells. Transfusion. 2000;40:252–253. - PubMed
-
- Busch MP, Operskalski EA, Mosley JW, Lee TH, Henrard D, Herman S, et al. Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study Group. J Infect Dis. 1996;174:26–33. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical